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A large number of alternative exons are spliced with tissue-specific patterns, but little is known about how such
patterns have evolved. Here, we study the conservation of the neuron-specific splicing factors Nova1 and Nova2 and of
the alternatively spliced exons they regulate in mouse brain. Whereas Nova RNA binding domains are 94% identical
across vertebrate species, Nova-dependent splicing silencer and enhancer elements (YCAY clusters) show much greater
divergence, as less than 50% of mouse YCAY clusters are conserved at orthologous positions in the zebrafish genome.
To study the relation between the evolution of tissue-specific splicing and YCAY clusters, we compared the brain-
specific splicing of Nova-regulated exons in zebrafish, chicken, and mouse. The presence of YCAY clusters in lower
vertebrates invariably predicted conservation of brain-specific splicing across species, whereas their absence in lower
vertebrates correlated with a loss of alternative splicing. We hypothesize that evolution of Nova-regulated splicing in
higher vertebrates proceeds mainly through changes in cis-acting elements, that tissue-specific splicing might in some
cases evolve in a single step corresponding to evolution of a YCAY cluster, and that the conservation level of YCAY
clusters relates to the functions encoded by the regulated RNAs.
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Introduction
Alternative splicing is believed to be one of the major
mechanisms by which proteome diversity is generated in
multicelullar organisms [1,2]. Initial estimates that 5% of
human genes are alternatively spliced [3] have recently been
revised, such that it is now believed that 40%–60% of human
genes are alternatively spliced [4,5]. A large number of these
alternative exons are spliced with brain-speciﬁc patterns, as
shown by microarray studies [6,7]. Such tissue-speciﬁc
splicing patterns require interactions between deﬁned cis-
acting sequences present in the vicinity of the alternative
exons and trans-acting regulatory factors [8,9]. It is still an
open question to what extent mutations in cis-acting
sequences or in genes encoding trans-acting regulatory
factors have contributed to the evolution of splicing
regulation [10,11], or to the development of neurologic
disease [12].
Analysis of the evolutionary conservation of alternative
exons can provide evidence of the regulation and functional
signiﬁcance of the exons. In addition, since alternatively
spliced exons and ﬂanking intronic regions are generally
more conserved than constitutive exons, analysis of evolu-
tionary conservation can be used to identify de novo
alternative exons and regulatory sequences [13]. Interestingly,
analysis of alternative exon conservation between human and
mouse transcriptomes revealed a relationship to their
inclusion level: major exons, included at over 50%, were
found to be highly conserved (98%), whereas minor exons,
included below 50%, were poorly conserved (26%) [14,15].
However, if a minor alternative exon shows a tissue-speciﬁc
splicing pattern, its conservation between human and mouse
rises to the level of major exons [16]. In general, exons with
tissue-speciﬁc splicing patterns have increased conservation
and frame preservation relative to other alternative exons
[16,17].
Nova is a brain-speciﬁc splicing factor, ﬁrst identiﬁed as an
antigen in a neurologic disorder termed paraneoplastic
opsoclonus-myoclonus ataxia [18]. Nova binds to clusters of
tetranucleotide YCAY motifs (YCAY clusters), which are
often present in the vicinity of Nova-regulated alternative
exons [19–22]. When these are positioned within 200
nucleotides of the splice sites, their position predicts whether
Nova functions to inhibit or enhance alternative exon
inclusion, following the rules of an RNA map. So far,
biochemical studies and analysis of mouse genomic sequence
have found 76 different YCAY clusters located within Nova-
regulated pre-mRNAs [6,20–24]. Fifty-four of these clusters
are located in genes that are expressed both in brain and
liver. This allowed us to analyze the splicing pattern of Nova-
regulated exons from brain and liver mRNA of different
vertebrates and relate it to the conservation of YCAY clusters.
We found that a brain-speciﬁc splicing pattern was conserved
across species in all (24/24) tested cases where YCAY clusters
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speciﬁc splicing pattern, which correlated with the absence of
detectable YCAY clusters in the corresponding pre-mRNAs.
Interestingly, in all of these cases, we also observed a loss of
alternative splicing (i.e., a single isoform detected in brain
and liver). This suggests that some RNAs might have acquired
brain-speciﬁc splicing regulation in a single step by addition
of the YCAY cluster, without the need for preliminary
mutations that would create an alternative exon.
Results
Recently, an RNA map was constructed to relate Nova-
dependent splicing regulation in brain to the position of its
binding site (YCAY cluster) on the pre-mRNA [24]. This RNA
map deﬁnes how YCAY clusters at ﬁve major positions on
pre-mRNA direct the action of Nova on the splicing of
neighboring alternative exons. At two such positions, YCAY
clusters act as splicing enhancers and at three positions as
splicing silencers. Seventy-six such YCAY clusters were found
within Nova-regulated pre-mRNAs, providing a tool to relate
the conservation of YCAY clusters to the evolution of brain-
speciﬁc splicing. Nova proteins show high conservation
between different vertebrate species, with the amino acid
sequence of Nova1 and Nova2 KH domains 94% identical
between zebraﬁsh and mouse orthologues (Figures 1A and
S1). Moreover, we found that both Nova1 and Nova2 bind to
similar YCAY clusters in vivo, using the cross-linking and
immunoprecipitation (CLIP) method ([22,25], unpublished
data). We also conﬁrmed that Nova expression is restricted to
the brain in chicken and zebraﬁsh (Figure 1B).
Given the highly conserved nature of the Nova proteins, we
hypothesized that the main driving force in the evolution of
Nova-dependent splicing regulation in vertebrate species
might be changes in YCAY clusters within pre-mRNAs. We
analyzed YCAY clusters in the pre-mRNAs containing 49
Nova-regulated exons that were previously identiﬁed by
splicing microarray analysis of Nova knockout mouse brain
[6]. Using the same YCAY cluster score algorithm as in the
previous study [24], we found that 30% of YCAY clusters were
conserved at orthologous zebraﬁsh positions (Table S1A).
This algorithm, which detects clusters with a maximum
distance of three nucleotides between YCAY motifs [24],
was written to be very stringent, since limiting the analysis to
the highest afﬁnity Nova-binding sites was important for
precision in deﬁning the original RNA map. However,
previous analyses of minimal functional Nova binding site
and of in vivo Nova–RNA interactions via the CLIP method
[19–23] have shown that in some cases more dispersed YCAY
clusters can be functional, even though they may bind Nova
with a lower afﬁnity. Indeed, manual analysis of sequence
alignments (Figure S2) shows that the orthologous sequences
often contain more dispersed YCAY clusters than the mouse
genome. To be able to take these YCAY clusters into account,
we modiﬁed the algorithm for the purpose of this study to
detect clusters with distance of up to nine nucleotides
between YCAY motifs. Analysis of gene sequences ortholo-
gous to mouse showed that 41% of the pre-mRNAs contain a
conserved YCAY cluster in zebraﬁsh, 66% in chicken, 82% in
opossum, and 94% in the human genome (Figure 2; Table
S1B).
To assess whether the presence of YCAY clusters can
predict conservation of brain-speciﬁc splicing in vertebrates
as an independent variable, we used RT-PCR to analyze
brain-speciﬁc splicing of orthologous exons in zebraﬁsh and
chicken. Seventy-six different YCAY clusters located within
the Nova-regulated pre-mRNAs were assigned a cluster score
 0.6 by analysis of mouse genomic sequence using the
modiﬁed YCAY cluster score algorithm [24] (Table S2 and
Figure 1. Analysis of Nova Protein in the Brain and Liver of Different
Vertebrate Species
(A) Protein alignment of the 100% conserved region of the Nova1 KH1
domain.
(B) Immunoblot analysis of brain and liver extract from mouse, chicken,
and zebrafish using polyclonal Nova and the eIF3a loading control
antibody. Protein (50 lg) was loaded in each lane. Mouse brain contains
an additional slower migrating Nova band that is not detected in chick
and zebrafish brain (but is present in human brain). In another study, we
cloned this slower migrating band and found that it binds to similar
YCAY clusters and regulates the same exons as the previously cloned
Nova1 and Nova2 isoforms (unpublished data).
The abbreviations for the following species are used: H. sapiens (hs), M.
musculus (mm), G. gallus (gg), and D. rerio (dr).
doi:10.1371/journal.pgen.0030173.g001
PLoS Genetics | www.plosgenetics.org October 2007 | Volume 3 | Issue 10 | e173 1839
Evolution of Nova Splicing
Author Summary
Alternative splicing generates different mRNA isoforms from a single
gene and thus increases the number of proteins a cell can produce.
This is particularly important in the brain, which possesses a number
of brain-specific splicing factors. In this study, we have looked at
evolution of brain-specific splicing regulation by one such factor,
Nova. Previous studies have identified ;100 alternative exons that
are regulated by Nova in mouse brain. We find that the Nova protein
sequence changed little during vertebrate evolution from fish to
human, whereas the RNA targets themselves have evolved
significantly. Interestingly, the presence of conserved Nova binding
elements in an RNA transcript in most cases correlates with
conservation of brain-specific splicing. In addition, the evolution of
Nova-dependent splicing relates to the functions encoded by the
target RNAs, such that Nova-regulated splicing of RNAs encoding
core roles such as synaptic adhesion, ion channel, and cytoskeletal
proteins is on average more conserved than splicing of the RNAs
encoding regulatory roles, such as transmembrane receptor and
signal transduction proteins.Materials and Methods). Fifty-four (54/76) of these clusters are
located in genes that are expressed both in brain and liver
(Table S3). We designed PCR primers for these genes using
cDNA and EST data or alignment of orthologous alternative
exons and ﬂanking constitutive exons. We were able to design
PCR primers and obtain RT-PCR data for 25 chicken
orthologous exons and 14 zebraﬁsh orthologous exons.
RT-PCR analysis showed a striking correlation between the
presence of YCAY clusters and the conservation of brain-
speciﬁc splicing. Together, we tested 39 independent splicing
events (25 in chicken and 14 in zebraﬁsh). In 24 cases, the
YCAY cluster was conserved (YCAY cluster score  0.6 in the
orthologous sequence), and RT-PCR analysis showed at least
20% change in exon inclusion between brain and liver in 23/
24 cases (jDIj.0.20, p,0.05, Figure 3; Table 1; Figure S2,
where DI is used as deﬁned previously [6]). In one case
(chicken efna5 gene), the difference in exon inclusion
between brain and liver was smaller, but still signiﬁcant (DI
¼  0.09 and p ¼ 0.008). Position of the YCAY cluster in all
cases correctly predicted the direction of alternative splicing,
following the rules of RNA map [24]. Seventeen splicing
enhancers predicted higher exon inclusion in the brain,
whereas seven splicing silencers predicted lower exon
inclusion in the brain relative to the liver.
In 15 cases, YCAY clusters were not conserved (YCAY
cluster score , 0.6 in the orthologous sequence). In 7/15
cases, RT-PCR detected no difference in splicing patterns of
brain and liver RNA (DI , 0.01), and in one case (Efna5 in
zebraﬁsh) the difference in splicing pattern was the reverse of
that seen in mouse. However, a signiﬁcant difference in the
splicing pattern of brain and liver RNA (p , 0.01) was
detected in the remaining 7/15 cases, and in each case the
change in splicing (inclusion or exclusion) was in the same
direction as that seen in the mouse (Figures 3 and S2; Table
1). Thus, in 8/15 cases, the absence of YCAY cluster correlated
with lack or reversal of a brain-speciﬁc splicing pattern,
whereas a brain-speciﬁc splicing pattern was conserved in
seven cases despite the absence of YCAY cluster in the pre-
mRNA.
Taken together, we found that brain-speciﬁc splicing was
conserved in all (24/24) pre-mRNAs containing YCAY
clusters, but only in 47% (7/15) of pre-mRNAs lacking YCAY
clusters. To address the statistical signiﬁcance of this
observation, we deﬁned our problem as a comparison of
these two binomial samples (ﬁrst with 24/24 and second with
7/15 conservation frequency), since no previous study is
available to deﬁne the expected frequency of brain-speciﬁc
splicing conservation between mouse, chicken, and zebraﬁsh.
This comparison shows that the presence of a conserved
YCAY cluster in pre-mRNA signiﬁcantly increases the like-
lihood of brain-speciﬁc splicing being conserved (p ¼ 0.0001,
one-sided Fisher exact test).
Nova-dependent splicing silencers in neogenin (Neog, Figure
4A) and syntaxin binding protein 2 (Stxbp2/Munc18–2, Figure 4B)
pre-mRNAs illustrate the correlations we observed between
the presence of YCAY clusters and alternative splicing. In
both cases, the YCAY cluster in mouse pre-mRNA spans both
sides of the 39 splice site, so that half of the cluster is intronic,
and the other half exonic. In neogenin pre-mRNA, the cluster
and brain-speciﬁc splicing pattern of exon exclusion are
Figure 2. Conservation of Mouse YCAY Clusters and Nova-Regulated
Alternative Exons in Different Vertebrates
We analyzed conservation of 49 mouse YCAY clusters that were
predicted by microarray. We observed a high degree of conservation
of YCAY clusters across species, with 94% conservation in human and
41% conservation in zebrafish. We also analyzed genomic conservation
of 88 mouse Nova-regulated alternative exons in vertebrates, based on
cDNA/EST data, genomic alignment, and sequencing. The results were
similar to conservation of YCAY clusters, with 56% of exons conserved in
zebrafish and 99% in human. Because cDNA/EST data is not complete
and may contain errors, we may have overestimated or underestimated
the level of alternative exon conservation, but in general our sequencing
results agreed very well with cDNA/EST or genomic prediction.
doi:10.1371/journal.pgen.0030173.g002
Figure 3. Comparison of YCAY Cluster Score to Brain-Specific Splicing in
Chicken and Zebrafish
The graph shows relative exon inclusion levels against calculated YCAY
cluster scores. Dashed lines indicate cut-off values for conserved YCAY
clusters (score . 0.6) and jDIj (20% change in exon inclusion between
brain and liver). Data for chicken are marked with full triangles and data
for zebrafish with empty triangles. From 24 cases in which exons had
conserved YCAY clusters, 17 were splicing enhancers (upper right part of
the graph, denoted with dotted line) and seven were splicing silencers
(lower left part of the graph, denoted with dotted line). Note that the
direction of splicing always correlates with the type of YCAY cluster
(enhancer versus silencer) present; therefore, the upper left and the
lower right part of the graph are empty. From 15 cases where YCAY
clusters were not conserved, seven showed no alternative splicing
(center of the graph, denoted with dotted square). Overall, we observed
31 cases where the presence of YCAY clusters matched with splicing
patterns in vivo. The exceptions that did not match with our prediction
were eight cases in which brain-specific splicing was present in the
absence of conserved YCAY clusters. The data drawn in this graph are
also shown in Table 1.
doi:10.1371/journal.pgen.0030173.g003
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Evolution of Nova Splicingconserved between zebraﬁsh, chicken, and mouse (Figure 4A).
However, Stxbp2 pre-mRNA contains a cluster of over three
YCAY motifs in human and mouse, but not in opossum,
chicken, and zebraﬁsh (Figure 4B). This lack of YCAY clusters
correlates with the absence of exon 3 exclusion in the brain
and liver of chicken or zebraﬁsh. This represents a case where
the absence of YCAY cluster correlates with a lack of
alternative splicing.
Nova-dependent splicing enhancers in protein tyrosine kinase,
receptor type F (Ptprf, Figure 4C), and amyloid beta (A4) precursor-
like protein 2 (Aplp2, Figure 4D) pre-mRNAs demonstrate that
brain-speciﬁc splicing is conserved at least as much as the
YCAY clusters. In Ptprf pre-mRNA, the YCAY cluster and the
brain-speciﬁc splicing patterns are conserved in all species
(Figure 4C). In Aplp2 pre-mRNA, the YCAY cluster is
conserved in chicken but not in zebraﬁsh, whereas the
brain-speciﬁc splicing pattern is conserved in all species
(Figure 4D). This represents one of the seven cases where
brain-speciﬁc splicing pattern is conserved in spite of the
absence of detectable YCAY clusters within the pre-mRNAs
(Figure 3).
A Nova-dependent splicing enhancer in suppression of
tumorigenicity (St7, Figure 4E) pre-mRNA demonstrates a
correlation between the emergence of the YCAY cluster
and the alternative exon 12a. Vertebrate alignment of the St7
genomic sequence shows an absence of conservation in the
region containing exon 12a in opossum, chicken, and
zebraﬁsh (Figure 4F). We detected no evidence of St7 exon
12a exon inclusion in brain and liver of chicken or zebraﬁsh,
exemplifying another case where a lack of YCAY clusters
correlates with a lack of alternative splicing. This observation
suggests that the YCAY cluster in St7 might have served to
create the exon 12a; in the future, this hypothesis can be
further analyzed using the genomic sequences of species
evolutionarily intermediate to opossum and mouse.
Since Nova-regulated exons encode proteins with synaptic
functions [6], analysis of their splicing conservation can
provide insight into the evolution of functionally coherent
coregulated networks (Figure 5). We ﬁnd that most RNAs with
conserved YCAY clusters encode adhesion and cytoskeletal
scaffold proteins, ion channels, and signaling proteins. Many
of these proteins have been implicated in neuronal develop-
ment, or function at the synaptic junction [26–28]. In
comparison, RNAs with YCAY clusters that are conserved
only in mammals encode receptors (such as glycine (GlyRa2)
and kainaite (GluR6) neurotransmitter receptors) and signal-
ing proteins (neurochondrin, Lrp12, Gpr45). It is possible
that RNAs with conserved YCAY clusters more often encode
proteins that are indispensable for synaptic development and
function, while the RNAs with YCAY clusters present only in
mammals more often encode proteins that modulate synaptic
function. This hypothesis cannot yet be statistically analyzed
since not enough is known about the detailed synaptic
functions of each Nova-regulated gene.
Discussion
Previous studies have shown that Nova regulates a module
of alternative exons that encode a functionally coherent set
of proteins. How did this relationship between an RNA-
binding protein and its set of RNA targets evolve? We
approached this question by analyzing evolutionary changes
in Nova proteins, YCAY clusters, and splicing of correspond-
ing alternative exons in mouse, chicken, and zebraﬁsh. In this
paper, we developed a hypothesis that evolution of Nova-
regulated splicing proceeds mainly through changes in cis-
acting elements, while Nova proteins themselves show little
evolutionary change.
This is the ﬁrst study to analyze the conservation of tissue-
speciﬁc splicing between species other than mouse and
human. While bioinformatic analysis shows alternative exon
conservation between mouse and human to be roughly 75%
[14], we ﬁnd ;80% (31/39) conservation of brain-speciﬁc
splicing patterns between evolutionarily much more diverse
mouse, chicken, and zebraﬁsh species. This estimate might be
Table 1. Comparison of YCAY Cluster Score to Brain-Specific
Splicing in Chicken and Zebrafish
Gene Exon YCAY Species YCAY
Cluster
Score
RT-PCR
(DI, Brain/
Liver)
Standard
Deviation
Agrn 31a NISE2 chick 0.30 0.04 0.010
Agrn 31a NISE2 fish 0.00 0.45 0.044
Ank3 31 NISS2 chick  1.00  0.24 0.011
Aplp2 12a NISE2 chick 1.08 0.89 0.030
Aplp2 12a NISE2 fish 0.00 0.89 0.030
Brd9 5 NISE1 chick 1.60 0.59 0.014
Brd9 5 NISE1 fish 1.00 0.46 0.040
Cacna1b 24a NISE2 chick 0.90 0.37 0.030
Cacna1b 24a NISE2 fish 0.60 0.49 0.033
Camk2g 13a NISE2 chick 1.26 0.56 0.029
Camk2g 13b NISE2 fish 1.45 0.24 0.013
Clasp1 9 NESE1 chick 0.00 0.17 0.020
Clstn1 10 NISE3 chick 0.00 0.73 0.009
Dab1 7c NISS2 chick  1.60  0.88 0.013
Efna5 3 NISS1 chick  0.90  0.09 0.008
Efna5 3 NISS1 fish 0.00 0.20 0.048
Epb4.1 14 nise2 chick 0.60 0.44 0.004
Epb4.1 14 nise2 fish 1.53 0.20 0.041
Epb41L2 12a NISE3 chick 0.60 0.22 0.029
Golga4 22a NISE3 chick 0.00 0.00 N/A
Gphn 7a NESS2 chick  0.90  0.85 0.044
Kcnma1 24a NESE1 chick 0.30 0.46 0.004
Kcnma1 24a NESE1 fish 0.78 0.71 0.014
Lrrfip1 17a NISE1 chick 0.60 0.87 0.036
Map4 18 NISS2 chick 0.00  0.42 0.020
Map4 18 NISS2 fish 0.00 0.00 N/A
Map4k4 23a NISS1 chick  1.38  0.30 0.008
Neo1 27 NESS1 chick  1.81  0.76 0.024
Neo1 27 NESS1 fish  1.89  0.73 0.016
Plcl3 22a NISE2/3 chick 0.90 0.38 0.031
Plcl3 22a NISE2/3 fish 0.90 0.65 0.006
Ptprf 6a NISE2 chick 1.00 0.34 0.038
Ptprf 6a NISE2 fish 1.48 0.69 0.025
Ptprf 19a NISE3 chick 0.90 0.63 0.009
St7 7 NISE2 chick 0.00 0.00 N/A
St7 7 NISE2 fish 0.00 0.00 N/A
Stxbp2 3 NESS chick 0.00 0.00 N/A
Stxbp2 3 NESS fish 0.00 0.00 N/A
Tacc2 10 NISE3 chick 0.00 0.00 N/A
Exons orthologous to mouse alternative exons that are regulated by Nova were analyzed
by RT-PCR in brain and liver RNA from chicken (G. gallus) and zebrafish (D. rerio). Twenty-
four chicken and 14 zebrafish exons were analyzed by RT-PCR. In 31 cases, splicing pattern
of alternative exons followed the conservation of the YCAY cluster, and in eight cases
tissue-specific splicing was present in spite of the absence of the YCAY cluster. Note that
in some cases we could not calculate DI and standard deviation because there was only
one band detectable on the gel (see also Figure S2).
doi:10.1371/journal.pgen.0030173.t001
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Evolution of Nova Splicinga bit higher than the average conservation rate, since we were
not able to deﬁne orthologous positions in chicken and
zebraﬁsh genomes to analyze splicing of a subset of Nova-
regulated exons, due to the lower level of their genomic
sequence conservation. However, the ﬁnding agrees with
previous comparisons of splicing in mouse and human tissues
showing that exons with tissue-speciﬁc splicing are more
conserved than the rest of the alternative exons [16,17]. It will
Figure 4. Five Examples of YCAY Cluster Conservation and RT-PCR Analysis of Associated Exons
Multiple nucleotide alignment of five YCAY clusters. Introns are in lowercase, exons in uppercase, YCAY silencer motifs in bold blue, and YCAY enhancer
motifs in bold red. The abbreviations for the following species are used: H. sapiens (hs), M. musculus (mm), M. domestica (md), G. gallus (gg), and D. rerio
(dr). Next to the alignment are RT-PCR data from wild-type and Nova2 knockout brain, and below are RT-PCR data from chicken and zebrafish brain and
liver and diagrams of the splicing pattern. Blue represents silencing, red enhancement by Nova, rectangles represent exons, and circles represent the
position of Nova binding.
(A) Nova-dependent splicing silencer in neogenin (Neo1) pre-mRNA and brain-specific splicing of exon 27 conserved.
(B) Nova-dependent splicing silencer in syntaxin binding protein 2 (Stxbp2/Munc18–2) pre-mRNA and brain-specific splicing of exon 3 are not
conserved.
(C) Nova-dependent splicing enhancer in protein tyrosine phosphatase, receptor type, F (Ptprf) pre-mRNA and brain-specific splicing of exon 6a are
conserved.
(D) Nova-dependent splicing enhancer is not conserved in zebrafish amyloid beta precursor-like protein 2 (Aplp2) pre-mRNA, in contrast with conserved
brain-specific splicing of exon 12a.
(E) Nova-dependent splicing enhancer in suppression of tumorigenicity 7 (St7) pre-mRNA and brain-specific splicing of exon 12a are not conserved.
(F) The diagram obtained from the human genome browser shows the human St7 mRNAs that either contain or exclude the alternative exon 12a.
Underneath, alignment of vertebrate genomes demonstrates lack of conservation in the region containing exon 12a in the genomes of oppossum,
chicken, and zebrafish.
doi:10.1371/journal.pgen.0030173.g004
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Evolution of Nova Splicingbe interesting in the future to study the conservation of
tissue-speciﬁc exons between such diverse species as ﬁsh and
human in order to test more generally if exons with brain-
speciﬁc pattern, in addition to those regulated by Nova, have
particularly high conservation rates.
This study modiﬁed the original YCAY cluster algorithm by
relaxing the requirement for the maximal distance between
two YCAY motifs from three to nine nucleotides. The greater
ability of the modiﬁed algorithm to detect conserved YCAY
clusters is evident by analyzing the 31 cases where RT-PCR
analysis in this study detected conservation of brain-speciﬁc
splicing in chicken or zebraﬁsh. Whereas the original more-
stringent algorithm detects YCAY clusters in only 15 cases,
the modiﬁed algorithm detects a conserved cluster in 24/31
cases (Table S1). A shortcoming of our current algorithm is
that it analyzes the YCAY motifs as being separated by a
linear RNA molecule, even though in reality YCAY motifs
that appear dispersed on a linear RNA may be in relatively
close proximity once the RNA assumes its in vivo structure.
This may be one reason why the original study did not detect
YCAY clusters in all the pre-mRNAs regulated by Nova in
mouse brain, and why the current study didn’t detect
conserved YCAY clusters in all cases where brain-speciﬁc
splicing pattern was conserved.
Of 15 pre-mRNAs in which we didn’t detect a conserved
YCAY cluster, seven had conserved brain-speciﬁc splicing
patterns. In these instances, our algorithm may be failing to
detect some types of conserved Nova-binding sites; in
particular, those where RNA structure might bring multiple
YCAY motifs in proximity. Alternatively, many alternative
exons are regulated by multiple cis-acting elements [29]. For
instance, splicing of alternative exon 19 in NMDA receptor1
(NR1) is regulated by Nova and several other factors
including Napor, hnRNP A1, hnRNP H, and CaM kinase IV
[30–32]. Thus, it is reasonable to believe that during a long
evolutionary time, the importance of different cis-acting sites
for the tissue-speciﬁc splicing pattern varies, allowing for
other factors to compensate for the absence of YCAY clusters
in these eight cases. We note that in our previous study [24],
we demonstrated that YCAY clusters located within 200
nucleotides of splice sites predict Nova-dependent splicing
regulation, but we do not know whether these clusters are the
only ones required for Nova action. It is possible that in some
cases Nova may be able to regulate its target exons via
additional YCAY clusters located in introns further than 200
nucleotides from the splice sites, which would have been
missed in this study.
We found seven cases of pre-mRNAs lacking brain-speciﬁc
splicing pattern and also lacking YCAY clusters. Interestingly,
in all of these cases, rather than just lacking tissue-speciﬁc
splicing, we detected no evidence of alternative splicing at all
in brain and liver. This observation contrasts with the
currently prevailing model, which proposes that tissue-
speciﬁc splicing generally evolves from the regulation of
preexisting alternative exons, so that mutations in consensus
59 and 39 splice sites and enhancer sequences would precede
subsequent mutations that lead to tissue-speciﬁc splicing
[10,33]. We observed no case where an alternative exon would
subsequently evolve a tissue-speciﬁc splicing pattern,
although our sample size was limited. Our data suggest that
tissue-speciﬁc splicing might have evolved directly, at least in
some cases. This model of direct evolution of Nova-depend-
ent alternative splicing is also supported by the observation
that splice site consensus scores and exonic enhancer density
in Nova-regulated exons are on average similar to constitu-
tive exons [24].
One of the exons that obtained a Nova-dependent brain-
speciﬁc splicing pattern in more recent evolution is Munc18–
2 (Stxbp2) exon 3. The role of Munc18–2 in the brain is
unexplored since an early study has termed it a non-neuronal
Munc18–1 (Stxbp1/Sec1) homologue [34]. However, given that
Nova regulates brain-speciﬁc splicing of its exon 3 in higher
mammals, Munc18–2 might play a similar role in regulating
neurotransmitter release as Munc18–1 [35], in a way that
would contribute to brain function of higher mammals.
There is an ongoing debate regarding the functional
signiﬁcance of splice variants, particularly those encoded by
minor exons [13,33,36–39]. Our study showed a high
conservation of Nova-regulated alternative exons regardless
of whether they are minor or major exons as assessed by
bioinformatic analysis of EST and cDNA sequences (Tables S4
and S5). Furthermore, the functional signiﬁcance of Nova-
regulated exons is corroborated by conservation of reading
frame; 70% (54/77) of internal cassette exons had a length
Figure 5. Conservation of YCAY Cluster Can Provide Insight into
Evolution of Functionally Coherent Coregulated Network
The diagram shows a subset of proteins encoded by Nova-regulated
transcripts for which we were able to obtain orthologous sequences for
analysis of YCAY cluster conservation. The color coding represents the
evolutionarily most distant species from mouse that contains a
conserved YCAY cluster. High YCAY cluster conservation is seen in RNAs
encoding adhesion and cytoskeletal scaffold proteins, ion channels, and
signaling proteins. In comparison, RNAs with lower YCAY cluster
conservation (limited to mammals) most often encode neurotransmitter
receptors (such as glycine [GlyRa2] and kainate [GluR6] receptors) and
signaling proteins (such as neurochondrin, Lrp12, and Gpr45).
doi:10.1371/journal.pgen.0030173.g005
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(Table S4), agreeing with previous reports that conserved
alternative exons show signiﬁcant increase in frame preser-
vation [16,17,33,40].
The composite Nova binding site allows variation in the
number and density of YCAY motifs to ﬁne tune the afﬁnity
of the RNA for Nova [18,19,21]. Furthermore, the quantitative
outcome of Nova binding might be reﬁned by changing the
position of YCAY clusters within the RNA [24]. However, we
observed no case where YCAY cluster would change in
position in a way that would qualitatively change the outcome
of Nova binding (i.e., change from a splicing enhancer to
silencer). We hypothesize that these features of Nova–RNA
binding might allow selection in higher vertebrates to act
gradually via changing the Nova binding site, rather than
Nova itself, similarly to other cases where cis-acting elements
were suggested as the main force for phenotypic evolution
[11]. Furthermore, the dynamic nature of the cis-acting
elements could help ﬁne tune the functional coherence of
the whole network of RNAs regulated by Nova (Figure 5),
which were found in previous studies to primarily encode
synaptic proteins [6,22,24]. In contrast, tight evolutionary
ﬁxation of Nova is essential to preserve regulation of an array
of brain-speciﬁc splicing events. Interestingly, evolutionary
ﬁxation in the vertebrate lineage does not apply to all
heterogeneous nuclear ribonucleoproteins, some of which
were found to vary in domain structure and even in their
presence/absence between mammals and ﬁsh [41,42].
The ﬁnding that a trans-acting factor such as Nova, which
regulates multiple genes, is more conserved than the cis-
acting sites that regulate individual genes might be antici-
pated, as it agrees with previous studies showing that
transcriptional and micro-RNA regulators evolve more slowly
than their target binding sites [11,43,44]. However, the
conservation of the cis-acting sites observed in this study is
surprisingly high, with 94% conservation of YCAY clusters
between mouse and human. In contrast, biochemical analysis
of cis-acting sites binding tissue-speciﬁc transcriptional
regulators has found that 19%–59% of sites are conserved
between mouse and human [45]. We have similarly observed
that when using a biochemical approach (CLIP) [22], the
majority of Nova-binding sites isolated from mouse brain are
not conserved in the human genome ([22], unpublished
observation). How can we reconcile the high conservation of
the functional Nova binding sites analyzed in the current
study with the much lower conservation of sites isolated via
biochemical studies? We hypothesize that in addition to the
highly conserved functional sites that were analyzed in this
study, Nova might also bind less conserved sites, which could
contribute to ability of the organism to evolve. To explore
this question further in the future, biochemical analysis of
Nova–RNA binding in brains of different species would need
to be related to the alternative exons regulated by Nova in
each species.
Taken together, the current work ﬁnds that brain-speciﬁc
splicing patterns of Nova-regulated exons are highly con-
served and are related to conservation of YCAY clusters in
the pre-mRNAs. The presence of YCAY clusters is 100%
predictive for the brain-speciﬁc alternative splicing of exons,
whereas their absence signiﬁcantly decreases the ratio of
conserved splicing to 47%. The data also agree with the
hypothesis that alternative splicing might in some cases
evolve via addition of cis-acting sites that bind tissue-speciﬁc
splicing factors such as Nova. Moreover, it is shown that the
genes encoding adhesion and cytoskeletal proteins generally
display deeper evolutionary ﬁxation of YCAY clusters than
the genes encoding receptors and signaling molecules,
suggesting evolution of Nova function through evolution of
target RNA sequences.
Materials and Methods
Genomic alignments. We searched for human (Homo sapiens),
opossum (Monodelphis domestica), chicken (Gallus gallus), frog (Xenopus
tropicalis), and zebraﬁsh (Danio rerio) genomic orthologous sequences
with the Liftover tool on University of California Santa Cruz (UCSC)
Genome Browser [46] using genomic data from March 2006 for
human, February 2006 for mouse, January 2006 for opossum, May
2006 for chicken, August 2006 for frog, and March 2006 for zebraﬁsh.
We used the UCSC Table Browser [47] (http://genome.ucsc.edu/
cgi-bin/hgTables) to download sequence ﬂanking the splice sites; we
analyzed 80 nucleotides of exonic sequence upstream of each 59
splice site, 200 nucleotides of intronic sequence downstream of each
59 splice site, 200 nucleotides of intronic sequence upstream of each
39 splice site, and 80 nucleotides of exonic sequence downstream of
each 39 splice site. Sequences were further veriﬁed for proper
alignment using MacVector ClustalW and T-Coffe multiple alignment
tool, and cases where multiple possible alignments were present in
the genome due to multiple paralogous matches were discarded.
Calculation of YCAY cluster score. We adjusted our original YCAY
cluster score algorithm [24] for the purpose of this evolutionary
study. Whereas the original paper [24] required stringent ﬁltering of
false positives due to analysis made on genomic scale, the current
algorithm allowed for larger toleration in distance between YCAY
motifs [22]. The majority of YCAY motifs are located in introns,
which display fast mutation rates between such distant species as ﬁsh
and mouse, and therefore the current algorithm was adapted to
tolerate such mutations in a way that still detects the core feature of
Nova binding site, i.e., three proximal YCAY motifs. In addition, the
deﬁnition of the boundaries between the areas where the clusters act
as silencers or enhancers was the same as in the previous study [24].
The YCAY cluster score was calculated by searching for the ﬁrst
YCAY motif, and then giving it a score relative to the pattern of
YCAY motifs that followed it:
if YCAY[N.23]YCAY then s ¼ 0
if YCAY[19,N,24]YCAY[[N,4]Y]CAY then s ¼ 2
if YCAY[9,N,20]YCAY[3,N,20]YCAY then s ¼ 2
if YCAY[9,N,20]YCAY[[N,4]Y]CAY then s ¼ 4
if YCAY[3,N,10]YCAY[9,N,20]YCAY then s ¼ 2
if YCAY[3,N,10]YCAY[3,N,10]YCAY then s ¼ 4
if YCAY[3,N,10]YCAY[[N,4]Y]CAY then s ¼ 6
if YCAY[[N,4]Y]CAY[19,N,24]YCAY then s ¼ 2
if YCAY[[N,4]Y]CAY[9,N,20]YCAY then s ¼ 4
if YCAY[[N,4]Y]CAY[3,N,10]YCAY then s ¼ 6
if YCAY[[N,4]Y]CAY[[N,4]Y]CAY then s ¼ 8
After the score is given to the ﬁrst YCAY, the analysis moves on to
the next YCAY, and so on in an iterative way until the end of the 45-
nucleotide sequence window is reached. At that point, the score is
calculated:
S¼log(s1þs2þ...þsn), where n is the number of YCAY motifs in
the 45-nucleotide sequence window.
In order to predict the direction of Nova-dependent splicing
regulation based on YCAY cluster position, net YCAY cluster score
was calculated as described previously [24] using the following
formula:
Net conserved S ¼ 1/2(MAX(NISE1, NISE2, NISE3, SUM(NISE2,
NISE3)*2/3)   MAX(NISS1, NISS2, NESE))
where NISE1 is nova intronic splicing enhancer 1, NISE2 is nova
intronic splicing enhancer 2, NISE3 is nova intronic splicing
enhancer 3, NISS1 is nova intronic splicing silencer 1, NISS2 is nova
intronic splicing silencer 2, NESE is nova exonic splicing enhancer.
RT-PCR. Puriﬁed RNA from brain or liver of chicken (G. gallus)
and zebraﬁsh (D. rerio) was reverse transcribed using random
hexamers, and cDNA products were ampliﬁed using Taq PCR Master
Mix Kit (Qiagen) with 40 pmol of each primer and 0.5 pmol of one
c-
32P-ATP-labeled primer at Tm¼55 8C. The primers used are listed
in Table S6. PCR products were resolved on polyacrylamide gel
electrophoresis and conﬁrmed by size and sequencing.
Western blot analysis. Brain and liver from chicken (G. gallus) and
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determined with Bradford dye assay (BioRad). Proteins were
separated by SDS/PAGE, transferred to nitrocellulose, and probed
with rabbit polyclonal anti-Nova antibody that was made by
immunization with full-length Nova1 [20] or rabbit polyclonal eIF3a
(Santa Cruz). Blots were developed with horseradish peroxidase–
linked secondary antibodies and enhanced chemiluminiescence
(Amersham).
Supporting Information
Figure S1. Alignment of Full-Length Nova1 and Nova2 Proteins in
Four Different Vertebrate species
Proteins were aligned using ClustalW (MacVector). KH domains are
marked with red letters.
Found at doi:10.1371/journal.pgen.0030173.sg001 (366 KB PDF).
Figure S2. Alignments of YCAY Clusters and Gel Pictures of RT-PCR
Results
Raw data are shown for all the genes, for which pattern of alternative
splicing was analyzed in chicken and/or zebraﬁsh brain and liver
mRNA. Alignments were made from orthologous sequences from
eight species: human (H. sapiens), dog (Canis familiaris), mouse (Mus
musculus), rat (Rattus norvegicus), opossum (M. domestica), chicken (G.
gallus), frog (X. tropicalis), and zebraﬁsh (D. rerio). Exon are capitalized
and introns in small letters. The letters marked in light blue indicate
intron/exon borders, YCAY sequences are marked with red, and the
main mouse Nova binding element is indicated in grey. Below the
alignment are results from RT-PCR experiments for chicken (G.
gallus) and zebraﬁsh (D. rerio), respectively. The picture also shows the
structures of different mRNA isoforms with Nova binding site
indicated (red circle for splicing enhancers and blue circle for
splicing silencers).
Agrin: The main mouse Nova binding cluster is not present in
chicken and zebraﬁsh. But the splicing pattern of alternative exon,
orthologous to mouse alternative exon 31a, in these two species is
similar to that in mouse, where Nova regulated alternative exon 31a is
more included in the brain. In both species, the alternative forms are
weakly expressed.
Ank3: Mouse niss2 cluster is very well conserved in chicken, but it is
not conserved in zebraﬁsh. Splicing of chicken alternative exon,
orthologous to mouse alternative exon 31, is conserved, with exon
more excluded in brain (and more included in liver). We were not
able to construct PCR primers for analyzing splicing of this
alternative exon in zebraﬁsh.
Aplp2: The main mouse YCAY cluster is conserved in chicken, but it
is not present in zebraﬁsh. Zebraﬁsh has no detectable YCAY clusters
in the downstream vicinity of the alternative exon. Splicing pattern of
alternative exon, orthologous to mouse exon 12a, is conserved in
both chicken and zebraﬁsh, with alternative exon being more
included in the brain. We also checked alternative splicing in
opossum, which has a conserved YCAY cluster and also found
conserved splicing pattern (unpublished data).
Brd9: The main mouse Nova binding cluster is extremely conserved
in chicken and also very good in zebraﬁsh. The splicing pattern of the
chicken and zebraﬁsh alternative exon, orthologous to mouse exon 5,
is also conserved in both organisms, with alternative exon more
included in the brain than in the liver. Note that the alternative exon
5 lies downstream of the YCAY cluster and is not shown in the
alignment.
Cacna1b: The main mouse Nova binding cluster is conserved in
chicken and zebraﬁsh. The zebraﬁsh cluster is located a little more
upstream than in other organisms and so it is not visible in this
alignment. Splicing pattern of the alternative exon, orthologous to
exon 24a in mouse, is conserved in both chicken and zebraﬁsh, with
the exon more included in the brain.
Interestingly, it looks like zebraﬁsh has a slightly different gene
structure from other organisms, with an additional alternative exon
adjacent to the known alternative exon.
Camk2g: The main mouse Nova binding cluster nise2 is not present in
chicken and zebraﬁsh (although it is conserved in human, dog, rat,
and opossum). Chicken and zebraﬁsh have a strong cluster located
more downstream (approximately 100 nt further away from the
alternative exon 13a than that of the mouse, which still corresponds
to the nise2 area), which is not shown in this alignment. In chicken,
the splicing pattern of the alternative exon, which is orthologous to
mouse alternative exon 13a, is the same as in mouse, with the exon
more included in the brain. In zebraﬁsh, it looks as though the exon
that is orthologous to mouse alternative exon 13b is more regulated,
possibly because of the position of the cluster.
Clasp1: Mouse nese1 cluster is not conserved in chicken, but it is
conserved in zebraﬁsh (where the cluster is even stronger than in
mouse, with ﬁve YCAY repeats). Interestingly, chicken has a splicing
pattern more similar to that of the alternative exon, orthologous to
mouse exon 9, than to that of the mouse, with the exon more
included in the brain. We were not able to construct PCR primers for
analyzing splicing of this alternative exon in zebraﬁsh.
Clstn1: The main mouse YCAY cluster is not conserved in chicken or
zebraﬁsh. Interestingly, the chicken alternative exon, which is
orthologous to mouse exon 10, has the same splicing pattern as in
mouse, with the exon predominantly included in the brain. We were
not able to construct PCR primers for analyzing splicing of this
alternative exon in zebraﬁsh.
Dab1: Mouse alternative exons 7b and 7c are preceded by niss2
elements. Exon 7b is not conserved in chicken, but it is conserved in
zebraﬁsh and the peptide sequence encoded by the two exons
suggests that one of the two exons was generated via a duplication
event during the evolution of mammals. Interestingly, these species
also lack one of the niss2 elements, suggesting that duplication of the
exon has also duplicated the upstream YCAY cluster. Splicing pattern
of the conserved exon 7c in chicken is the same as in mouse, with the
exon predominantly excluded in the brain. It looks as though in
zebraﬁsh both exons are conserved, with a conserved pattern of
splicing (more often excluded in the brain). The gel has only three
bands because both exons are probably the same length.
Efna5: The main mouse Nova binding cluster is conserved in chicken,
but is not present in ﬁsh (where the whole area is actually missing).
Splicing pattern of alternative exon, orthologous to mouse exon 3a, is
conserved, with exon slightly more excluded in the brain than in the
liver. Interestingly, the zebraﬁsh alternative exon also shows a brain-
speciﬁc splicing pattern, although the pattern is reversed, with the
exon more included in the brain.
Epb4.1: The main mouse Nova binding cluster is conserved. Chicken
has a weak YCAY cluster (the distance between the ﬁrst and second
YCAY is 17 nt and 0 nt between the second and third cluster,
respectively), and zebraﬁsh has a stronger cluster with ﬁve YCAY
tetranucleotides (5 nt between the ﬁrst and second YCAY, 1 between
the second and third, 4 nt between third and fourth, and 3 nt between
fourth and ﬁfth). Splicing pattern of exon, orthologous to mouse
alternative exon 14, is conserved in chicken, with the exon more
included in the brain. In zebraﬁsh, it looks like the exon orthologous
to mouse alternative exon 13 has a conserved tissue-speciﬁc splicing
pattern.
Epb41L2: Mouse alternative exon 12a and 12b are controlled by two
YCAY clusters, nise2 and nise3. Neither of these clusters is conserved
in the chicken (we could not obtain orthologous sequence for
zebraﬁsh), but chicken has one YCAY cluster in a very similar
position to that of the mouse nise3 cluster. Both alternative exons in
chicken display a tissue-speciﬁc splicing pattern, with the exon
orthologous to mouse exon 12a more included in the liver, while the
exon orthologous to mouse exon 12b is more included in the brain.
Gphn: Mouse niss1 cluster is not conserved in chicken or zebraﬁsh.
On the other hand, mouse niss2 and ness2 clusters are completely
conserved in chicken (we could not get the orthologous sequence for
zebraﬁsh). Splicing pattern of the chicken exon orthologous to mouse
alternative exon 7a is the same as in mouse, with the exon
predominantly excluded in the brain (and predominantly included
in liver).
Golga4: The main mouse Nova binding cluster is not conserved in
chicken (we could not obtain orthologous sequence for zebraﬁsh) and
the exon orthologous to the mouse alternative exon is not present in
chicken, so there is no alternative splicing present.
Kcnma1: The main mouse Nova binding cluster is located in the 59
constitutive exon; in chicken, this YCAY cluster is not conserved, but
in zebraﬁsh, this cluster is very similar to that in mouse, with four
YCAY motives ( 1 nt between the ﬁrst and second YCAY, 11 nt
between the second and third, and  1 nt between the third and
fourth). The splicing pattern of the alternative exon orthologous to
mouse exon 24a is conserved both in chicken (even though here the
YCAY cluster is not conserved) and zebraﬁsh, with the exon more
included in the brain.
Lrrﬁp1: The mouse nise1 element, located in alternative exon 17a, is
conserved in chicken, but it is not present in zebraﬁsh. Note that
mouse alternative exon 17 acts as an alternative 39 mRNA end.
Splicing of the alternative exon orthologous to mouse exon 17a is
conserved in chicken (even though the YCAY cluster is not
conserved), with the exon more included in the brain. We were not
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alternative exon in zebraﬁsh.
Map4: The main mouse Nova binding cluster is not present in
chicken and zebraﬁsh. Chicken has similar splicing pattern to mouse
(exon more excluded in brain, compared to liver), while in zebraﬁsh
there is only one form of the transcript (with exon included) and
there is no splicing, even though the exon is conserved.
Map4k4: In mouse, Nova binds to two YCAY clusters in the vicinity of
alternative exon 22a, niss1 and ness2. We obtained orthologous
sequences only for the ness2 element, which is present in the
alternative exon. The element is completely conserved in chicken, but
is absent in zebraﬁsh. In chicken, splicing of the exon orthologous to
mouse alternative exon 22a follows the conservation of the ness2
element, with more exon exclusion in brain than in liver. We were
not able to construct PCR primers for analyzing splicing of this
alternative exon in zebraﬁsh.
Neo1: The main mouse Nova binding cluster is located in alternative
exon 27 and is almost perfectly conserved in all species (chicken and
zebraﬁsh actually have one additional YCAY sequence). The exon
orthologous to mouse alternative exon 27 is predominantly excluded
in the brain of chicken and zebraﬁsh (slightly more in zebraﬁsh [76%
versus 90%]).
Plcl3: The main mouse Nova binding cluster is conserved in chicken,
but is not conserved in zebraﬁsh. Zebraﬁsh has one YCAY cluster
located very close (3 nt) to the 59 end of the alternative exon (chicken:
4 nt between ﬁrst and second YCAY, 1 nt between second and third
YCAY; ﬁsh: 4 nt between ﬁrst and second YCAY, 12 nt between
second and third YCAY). Splicing of the exon orthologous to mouse
alternative exon 22a is conserved in both chicken and zebraﬁsh, with
the exon more included in the brain.
Ptprf: The main mouse Nova binding cluster is present in chicken
and zebraﬁsh, with ﬁve YCAY tetranucleotides in zebraﬁsh versus
three in chicken. The splicing pattern in chicken and zebraﬁsh of the
exon orthologous to mouse alternative exon 6a is very similar to that
in the mouse, where the exon is predominantly excluded outside
brain.
Ptprf: Alternative exon 19a in mouse is regulated by two Nova
binding sites, nise3 and nese2 element. Neither of the two elements is
conserved in chicken or zebraﬁsh (even though the element nese2 is
located in the 59 constitutive exon, which is strongly conserved). But
there is also a conserved YCAY cluster, preceding the nise3 element,
which is present in chicken but not in zebraﬁsh. (We could not obtain
the orthologous sequence from opossum, so we excluded this
sequence from our nucleotide alignment). The splicing pattern of
the chicken exon orthologous to mouse alternative exon 19a is the
same as in mouse, where the exon is more included in the brain. We
were not able to construct PCR primers for analyzing splicing of this
alternative exon in zebraﬁsh.
St7: Genomes of chicken and zebraﬁsh does not have sequence
orthologous to the mouse Nova-regulated alternative exon 7 and
downstream sequence containing the Nova binding site. The PCR of
chicken and zebraﬁsh brain and liver showed only one form of this
gene and the exon was not present.
Stxbp2: The main mouse Nova binding cluster is located on the
border of alternative exon 3. The cluster is not conserved in either
chicken or zebraﬁsh. On the other hand, the exon orthologous to
mouse alternative exon 3 is conserved in both organisms. The exon
shows no alternative splicing in these two organisms and the only
detected form is the one with the exon included.
Tacc2: The mouse nise3 cluster is not conserved in chicken (we could
not obtain orthologous sequence for zebraﬁsh).Although mouse
alternative exon 10 is strongly conserved in chicken (even in exon
length), it is not alternatively spliced but is constitutively included
into mRNA. In addition, expression of the gene is low in liver. We
were not able to construct PCR primers for analyzing splicing of this
alternative exon in zebraﬁsh.
Found at doi:10.1371/journal.pgen.0030173.sg002 (1.4 MB PDF).
Table S1. YCAY Cluster Scores of Orthologous Sequences within Pre-
mRNAs That Were Identiﬁed by Splicing Microarray As Regulated by
Nova in Mouse Brain
Analysis of YCAY cluster scores in human (H. sapiens), opossum (M.
domestica), chicken (G. gallus), frog (X. tropicalis), and zebraﬁsh (D. rerio)
sequences. In Table S1A, YCAY cluster score was calculated using the
original algorithm parameters [24]. In Table S1B, YCAY cluster score
was calculated according to the algorithm given in this paper. The
YCAY cluster was considered conserved if the absolute value of the
calculated cluster score was  0.6. For some mouse sequences we
could not obtain orthologous opossum, chicken, frog, and zebraﬁsh
sequences. On the other hand, some mouse sequences (such as Golga4
and St7 sequences containing YCAY clusters) were not present in the
genomes of other species.
Found at doi:10.1371/journal.pgen.0030173.st001 (251 KB DOC).
Table S2. Scores of YCAY Clusters in Pre-mRNA of All Validated
Mouse Nova-Regulated Exons Included in This Study, Together with
Exon Inclusion Levels
Seventy-six of YCAY clusters were assigned an absolute cluster score
value  0.6 by analysis of mouse genomic sequence using our YCAY
cluster score algorithm (see Materials and Methods).
Found at doi:10.1371/journal.pgen.0030173.st002 (146 KB DOC).
Table S3. Expression Levels of Nova-Regulated Genes in Mouse Brain
and Liver
Expression levels (the median value of microarray signal in RNA from
the tissue) of Nova-regulated genes were obtained from the Novartis
GNF1m gene atlas (http://symatlas.gnf.org/) and in cases where there
were no data for a particular gene, we searched for data from the
splicing microarray of the Nova knockout mouse brain (http://
splicing.rockefeller.edu/) and from the ArrayExpress repository for
microarray data at the European Bioinformatics Institute (http://www.
ebi.ac.uk/arrayexpress/). We assumed that genes with expression
values ,200 are not expressed in that tissue. We found 40 genes
that had an expression value in liver .200. For the remaining genes
that were interesting for our study but had an expression value ,200,
we manually checked their expression pattern in brain and liver with
RT-PCR. From those genes, we could detect eight in the liver. For
three genes (Brd9, Cp110, and Skip) there were no data about their
expression in the above-mentioned databases. We examined their
expression pattern with RT-PCR and found that Brd9 and Cp110 are
expressed in brain and liver, while we could not detect Skip in the
liver. Overall, we determined that from our list, 54 YCAY clusters
were present in genes that are expressed in liver.
Found at doi:10.1371/journal.pgen.0030173.st003 (197 KB DOC).
Table S4. Exon Length Conservation of 88 Mouse Nova Alternative
Exons in Different Vertebrate Species
The table shows exon length (in nucleotides) and predicted major/
minor form (based on mRNA and EST data in mouse) of alternative
exons validated as being regulated by Nova in mouse brain. Genomic
conservation of alternative exons was determined with Liftover and
Blat tools on the UCSC Genome Browser and in some cases
conﬁrmed with RT-PCR and sequencing. For some exons we could
not determine the exon length (e.g., because there were multiple
mRNA entries in the database with different lengths of the exon) or if
they are conserved or not (e.g., genomic alignment indicated that the
exon is conserved but then we could not reliably conﬁrm that with
Blat tool).
Found at doi:10.1371/journal.pgen.0030173.st004 (227 KB DOC).
Table S5. Homology of Orthologous Alternative Exons
The table shows percent identity between the mouse exon and the
orthologous exon in different vertebrate species for all cases where
we could obtain orthologous sequences.
Found at doi:10.1371/journal.pgen.0030173.st005 (194 KB DOC).
Table S6. List of PCR Primer Sequences
Found at doi:10.1371/journal.pgen.0030173.st006 (75 KB DOC).
Accession Numbers
The National Center for Biotechnology Information (NCBI) Entrez
Gene (http://www.ncbi.nlm.nih.gov) accession numbers of the mouse
genes discussed in this paper are: Neo, 4756; Stxbp2/Munc18–2,
81804; Ptprf, 5792; Aplp2, 11804; St7, 64213; Nova1, 18134; Nova2,
384569; GlyRa2, 237213; GluR6, 54257; neurochondrin, 26562; Lrp12,
239393; Gpr45, 93690; NR1, 14810; Napor, 14007; hnRNP A1, 15382;
hnRNP H, 59013; and CaM kinase IV, 12326.
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